Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Tymianski

Showing results (1-10 of 156) with videos related to

Pageof 16
Sort By:
Stroke|October 8, 2011
Aspirin as a promising agent for decreasing incidence of cerebral aneurysm ruptureMichael Tymianski
Stroke|February 7, 2024
Role of Neuroprotective Approaches in the Recanalization EraMichael Tymianski
Nature Neuroscience|October 28, 2011
Emerging mechanisms of disrupted cellular signaling in brain ischemiaMichael Tymianski
Stroke|September 30, 2010
Can molecular and cellular neuroprotection be translated into therapies for patients?: yes, but not the way we tried it beforeMichael Tymianski
Stroke|May 11, 2017
Combining Neuroprotection With Endovascular Treatment of Acute Stroke: Is There Hope?Michael Tymianski
Science Translational Medicine|August 7, 2015
Neuroprotective therapies: Preclinical reproducibility is only part of the problemMichael Tymianski
Idrugs : the Investigational Drugs Journal|April 8, 2009
International Stroke Conference 2009. Translation of high impact targets into clinical trials. 17-20 February 2009, San Diego, CA, USAMichael Tymianski
Stroke|September 12, 2013
Novel approaches to neuroprotection trials in acute ischemic strokeMichael Tymianski
Nature Reviews. Neurology|January 8, 2014
Stroke in 2013: disappointments and advances in acute stroke interventionMichael Tymianski
Neuropharmacology|December 6, 2017
Neurotransmitters in the mediation of cerebral ischemic injuryDiana Mayor, Michael Tymianski
Pageof 16

Showing results (1-10 of 156) with videos related to

Sort By:
Pageof 16
Stroke|October 8, 2011
Aspirin as a promising agent for decreasing incidence of cerebral aneurysm ruptureMichael Tymianski
Stroke|February 7, 2024
Role of Neuroprotective Approaches in the Recanalization EraMichael Tymianski
Nature Neuroscience|October 28, 2011
Emerging mechanisms of disrupted cellular signaling in brain ischemiaMichael Tymianski
Stroke|September 30, 2010
Can molecular and cellular neuroprotection be translated into therapies for patients?: yes, but not the way we tried it beforeMichael Tymianski
Stroke|May 11, 2017
Combining Neuroprotection With Endovascular Treatment of Acute Stroke: Is There Hope?Michael Tymianski
Science Translational Medicine|August 7, 2015
Neuroprotective therapies: Preclinical reproducibility is only part of the problemMichael Tymianski
Idrugs : the Investigational Drugs Journal|April 8, 2009
International Stroke Conference 2009. Translation of high impact targets into clinical trials. 17-20 February 2009, San Diego, CA, USAMichael Tymianski
Stroke|September 12, 2013
Novel approaches to neuroprotection trials in acute ischemic strokeMichael Tymianski
Nature Reviews. Neurology|January 8, 2014
Stroke in 2013: disappointments and advances in acute stroke interventionMichael Tymianski
Neuropharmacology|December 6, 2017
Neurotransmitters in the mediation of cerebral ischemic injuryDiana Mayor, Michael Tymianski
Pageof 16